Response to Commentary on "Are some invertebrates exquisitely sensitive to the human pharmaceutical fluoxetine?"

Aquatic Toxicology

Volumn 146, Issue , 2014, Pages 264-265

  Franzellitti, S ^a   Fabbri, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FLUOXETINE; STEROID;

ACUTE TOXICITY; CARBOHYDRATE METABOLISM; CHRONIC TOXICITY; CONCENTRATION (PARAMETERS); DOWN REGULATION; ECOTOXICITY; ENERGY METABOLISM; HUMAN; INVERTEBRATE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXICITY TESTING;

INVERTEBRATA;

ANIMALS; FLUOXETINE; GENE EXPRESSION REGULATION; MYTILUS; PROPRANOLOL; WATER POLLUTANTS, CHEMICAL;

EID: 84891496931     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2013.11.019     Document Type: Note

References (16)

1. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010, 29:730-741.
2. Ankley G.T., Brooks B.W., Huggett D.B., Sumpter J.P. Repeating history: pharmaceuticals in the environment. Environ. Sci. Technol. 2007, 41:8211-8217.
3. Contardo-Jara V., Lorenz C., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. Exposure to human pharmaceuticals carbamazepine ibuprofen and bezafibrate causes molecular effects in Dreissena polymorpha. Aquat. Toxicol. 2011, 105:428-437.
4. Dailianis S., Domouhtsidou G.P., Raftopoulou E., Kaloyianni M., Dimitriadis V.K. Evaluation of neutral red retention assay, micronucleus test, acetylcholinesterase activity and a signal transduction molecule (cAMP) in tissues of Mytilus galloprovincialis (L.), in pollution monitoring. Mar. Environ. Res. 2003, 56:443-470.
5. Fabbri E., Capuzzo A. Cyclic AMP signaling in bivalve molluscs: an overview. J. Exp. Zool. A 2010, 313:179-200.
6. Franzellitti S., Buratti S., Valbonesi P., Fabbri E. The mode of action (MOA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis. Aquat. Toxicol. 2013, 140-141:249-256.
7. Franzellitti S., Fabbri E. Cyclic-AMP mediated regulation of ABCB mRNA expression in mussel haemocytes. PLoS ONE 2013, 8:e61634.
8. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 2008, 42:5807-5813.
9. Huggett D.B., Ericson J.F., Cook J.C., Williams R.T. Plasma concentrations of human pharmaceuticals as predictors of pharmacological responses in fish. Pharmaceuticals in the Environment: Sources, Fate, effects and Risks 2004, Springer-Verlag, Berlin, (Chapter 27). 2nd ed. Kummerer (Ed.).
10. Lam D.D., Heisler L.K. Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert Rev. Mol. Med. 2007, 9:1-24.
11. Lazzara R., Blázquez M., Porte C., Barata C. Low environmental levels of fluoxetine induce spawning and changes in endogenous estradiol levels in the zebra mussel Dreissena polymorpha. Aquat. Toxicol. 2012, 106-107:123-130.
12. Martin-Diaz M.L., Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. Effects of environmental concentrations of the antiepileptic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 2009, 94:177-185.
13. Mennigen J.A., Sassine J., Trudeau V.L., Moon T.W. Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. Aquat. Toxicol. 2010, 100:128-137.
14. Raftopoulou E.K., Dailianis S., Dimitriadis V.K., Kaloyianni M. Introduction of cAMP and establishment of neutral lipids alterations as pollution biomarkers using the mussel Mytilus galloprovincialis. Correlation with a battery of biomarkers. Sci. Total Environ. 2006, 368:597-614.
15. Rand-Weaver M., Margiotta-Casaluci L., Patel A., Panter G.H., Owen S.F., Sumpter J.P. The read-across hypothesis and environmental risk assessment of pharmaceuticals. Environ. Sci. Technol. 2013, 47:11384-11395.
16. Schmitt H., Boucard T., Garric J., Jensen J., Parrott J., Péry A., Römbke J., Straub J.-O., Hutchinson T.H., Sánchez-Argüello P., Wennmalm A., Duis K. Recommendations on the environmental risk assessment of pharmaceuticals: effect characterization. Integr. Environ. Assess. Manag. 2010, 6:S588-S602.